GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lifecare A LIFE.OL · NOK

Health Care · Oslo Børs · 🇳🇴 Norway

Compare

0.40

-2.09%

Close of 9 Nov 2026, in NOK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Lifecare A

Its shares trade on Oslo Børs under the ticker LIFE.OL. It has been listed since 10 July 2018. In the fiscal year to 31 December 2025, it reported revenue of NOK 112,000 and a net loss of NOK 119.5m. At that date it held total assets of NOK 94.7m and shareholders' equity of −NOK 27.2m.

Lifecare AS engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
10 Jul 2018
Website
lifecare.no ↗

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Bergen, Norway
  • Focus on medical sensor development for health monitoring
  • IPO in 2018 with a specific product Sencell for glucose monitoring

Weaknesses

  • Limited to medical sensor development without broader product diversification
  • Reliance on a single product Sencell for glucose monitoring
  • No mention of financial performance or market share data

Opportunities

  • Expansion into other medical molecule detection using osmotic pressure technology
  • Potential market growth in diabetes management solutions
  • Technology applicable to a wide range of molecules in the human body

Threats

  • Competition in the medical sensor market without specified competitors
  • Dependence on a single product for revenue generation
  • Unverified claims about technology capabilities in source description

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.